People impacted by inflammatory bowel disease (IBD) and disorders of gut-brain interaction (DGBI) suffer from physical and psychosocial issues.
The complexity of disease, unmet needs, and limitations of existing disease management justify better ways of delivering care to people with IBD or DGBI, all of which led to the inception of the One×One Summit Series Coalition.
This is a coalition of diverse representation formed by leading providers, payors, advocates, professional organization members, and people with IBD or DGBI with the goal of advancing multidisciplinary care models (MCMs).
This initiative encompasses the following: to advocate for the standardization, adoption, and scalability of high-quality MCMs across diverse geographies and practice settings to improve quality of life and clinical outcomes, enhance equity, and reduce healthcare costs for people with IBD and DGBI.
Click here to read
the whitepaper
One of the main drivers of improved outcomes in IBD is a dedicated team of IBD professionals. The old practice structure that allowed all GIs to care for IBD is an outdated one. IBD is too complex to be managed by all GIs. In addition, the GI cannot manage it alone. A multidisciplinary team of committed professionals is required.”
Lawrence R. Kosinski, MD, MBA
Founder and Chief Medical Officer, SonarMD
Rachel Adams, PhD, MS, RDN* Senior Director, US Medical Communications, Takeda Pharmaceuticals
Hansa Bhargava, MD, FAAP Past Medical Director, Medscape
Joan Bishop Emeritus Executive Director, The Oley Foundation
Mena Boules, MD* Past Executive Medical Director, Gastroenterology, Takeda Pharmaceuticals
Ninfa Candela, MD Sr. Medical Director, Clinical Science, Gastroenterology, Takeda
Susan A. Cantrell, RPh, MHL, CAE Chief Executive Officer, Academy of Managed Care Pharmacy, Professional Organization
William D. Chey, MD, AGAF, FACG, FACP, RFF Chief, Division of Gastroenterology and Hepatology, H. Marvin Pollard Professor of Gastroenterology, Professor, Department of Internal Medicine Professor, Department of Nutritional Sciences
Paul Feuerstadt, MD Attending Gastroenterologist/Assistant Clinical Professor of Medicine, PACT-Gastroenterology Center/Yale New Haven Hospital
Michele Rubin MSN, APRN, CNS-BC, CGRN* Associate APRN Director IBD/Colorectal Center, University of Chicago Medicine, Crohn’s Colitis Foundation Advances Practice, Provider/Committee Director of IBD APP, Preceptorship Program
Eric Shah, MD, MBA Director, GI Motility, Assistant Professor of Medicine, Dartmouth Hitchcock Medical Center
Samir Shah, MD, FACG Past President, American College of Gastroenterology, Professional Organization
Kenneth I. Freedman, MD, MS, MBA* Sr. Medical Director, Southeast Territory, Aetna® Medical Affairs, CVS Health®
Tedra Gray, MSN, ACNP Nurse Practitioner, Division of Gastroenterology, Sinai Health Systems
Caren Heller, MD Chief Scientific Advisor, Crohn’s & Colitis Foundation
Julia Jackson Lead, Product Experience and Innovation, Takeda Pharmaceuticals
Lawrence Kosinski, MD, MBA Founder and Chief Medical Officer, SonarMD
John Mahalchak Patient
Melodie Narain-Blackwell* President & Founder, Color of Gastrointestial Illness (COGI)
Barbara Olendzki, RD, MPH, LDN Director of Center of Applied Nutrition, UMass Chan Medical School
Ceciel Rooker* Executive Director, International Foundation for Gastrointestinal Disorders
Brian Terreri, PharmD, MBA* Scientific Director, Gastroenterology, Takeda Pharmaceuticals
Lauren Tokarewich, MLIS Senior Manager, Programs, National Alliance for Caregiving
Jason Wagner, PharmD* Director, Account Medical Lead
*Steering Committee Member
Facilitated by Takeda
Copyright © Takeda Pharmaceuticals U.S.A., Inc. All rights reserved. TAKEDA and the Takeda logo are registered trademarks of Takeda or its affiliates.